Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Winlevi for acne

Aug. 27, 2020

Conditional E.U. approval for Idefirix for highly sensitized kidney transplant patients

Aug. 27, 2020

Keytruda receives two new approvals in Japan

Aug. 25, 2020

Velexbru granted supplemental approval in Japan

Aug. 24, 2020

FDA approves Olinvyk for acute pain

Aug. 10, 2020

FDA approves Evrysdi for spinal muscular atrophy

Aug. 10, 2020

FDA approves Blenrep for relapsed or refractory multiple myeloma

Aug. 6, 2020

European Commission grants conditional marketing authorization for Hepcludex

Aug. 5, 2020

Spravato antidepressant nasal spray approved in the U.S. for MDD with suicidal ideation

Aug. 4, 2020

Cosentyx approved in the E.U. for pediatric psoriasis

Aug. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...